Deerfield Management Co., 10% Owner at ANTARES PHARMA, INC. (ATRS), sold 713,222 shares at $2.18 ($1.5M) on 2015-06-29, disclosed to the SEC on 2015-07-01.
Open-market sale of $1.5M ATRS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.18 | 11,185 | $24K | 1.6% |
| 2 | $2.18 | 27,726 | $60K | 4.1% |
| 3 | $2.18 | 21,784 | $47K | 3.2% |
| 4 | $2.08 | 82,300 | $171K | 11.5% |
| 5 | $2.08 | 136,170 | $283K | 19.0% |
| 6 | $2.08 | 173,307 |
| $360K |
| 24.2% |
| 7 | $2.08 | 104,745 | $218K | 14.6% |
| 8 | $2.08 | 42,255 | $88K | 5.9% |
| 9 | $2.08 | 69,914 | $145K | 9.8% |
| 10 | $2.10 | 14,624 | $31K | 2.1% |
| 11 | $2.10 | 18,612 | $39K | 2.6% |
| 12 | $2.11 | 4,664 | $10K | 0.7% |
| 13 | $2.11 | 5,936 | $13K | 0.8% |
| Total | $2.09 avg | 713,222 | $1.5M | 100% |
| Filing → |
| CASM | SELL | 2017-01-23 | $314K | — | Filing → |
| ZFGN | SELL | 2016-08-01 | $4.4M | — | Filing → |
| EHTH | SELL | 2016-06-02 | $1.4M | — | Filing → |